Todd Franklin Watanabe
See Remarks at Arcutis Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arcutis Biotherapeutics Inc. June 5, 202681.2%
-
Arcutis Biotherapeutics Inc. June 2, 202388.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −4,375 | $26.12 | $114,261 |
| May 4, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −3,172 | $23.61 | $74,891 |
| Mar 2, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −36,281 | $25.16 | $912,830 |
| Mar 2, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −1,068 | $25.91 | $27,672 |
| Feb 27, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +102,000 | — | — |
| Feb 2, 2026 | Arcutis Biotherapeutics Inc. | Open-market sale | −19,833 | $25.50 | $505,742 |
| Nov 24, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −48,945 | $30.36 | $1,485,970 |
| Nov 21, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −1,055 | $30.00 | $31,650 |
| Nov 3, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −11,478 | $24.71 | $283,621 |
| Nov 3, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −69 | $25.40 | $1,753 |
| Oct 28, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −40,000 | $25.03 | $1,001,200 |
| Oct 2, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −20,739 | $20.04 | $415,610 |
| Oct 1, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −15,000 | $18.91 | $283,650 |
| Oct 1, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −9,261 | $20.02 | $185,405 |
| Sep 9, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −504 | $17.52 | $8,830 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.